Skip to content

To analyze the efficacy and safety of symmetrical single-port +2 around the umbilicus laparoscopic total colectomy in the treatment of chronic refractory constipation

To analyze the efficacy and safety of symmetrical single-port +2 around the umbilicus laparoscopic total colectomy in the treatment of chronic refractory constipation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400089813
Enrollment
Unknown
Registered
2024-09-18
Start date
2025-04-02
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractory constipation

Interventions

Sponsors

Northern Jiangsu People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1: Loose stools are rarely present without laxatives 2: They met Rome IV criteria for constipation and had a history of more than 2 years. 3: Does not meet the diagnostic criteria for irritable bowel syndrome 4: Modified transmission test and defecation imaging diagnosis of slow shows or mixed constipation 5: Medical treatment was ineffective

Exclusion criteria

Exclusion criteria: 1: Organic diseases and drug-induced constipation 2: Merger intentional, liver, kidney, blood and other body implement qualitative sex disease 3: Merged thyroid diseases such as endocrine diseases and metabolic diseases 4: Long-term use of sedatives, antidepressants, anticholinergic drugs, antipsychotic drugs, calcium channel blockers and other constipation-causing drugs 5: Concomitant muscle diseases

Design outcomes

Primary

MeasureTime frame
Frequency of bowel movements;Degree of constipation;

Secondary

MeasureTime frame
Depression;Anxiety;Quality of life;The duration of the operation;Intraoperative blood loss;Markers of inflammation;Postoperative Adverse Events;Length of stay;

Countries

China

Contacts

Public ContactTang Dong

Northern Jiangsu People's Hospital

18952783556@yzu.edu.cn+86 189 5278 3556

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026